Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Angiotensin II Receptor Blockers (ARB) and Angiotensin Converting Enzyme Inhibitors (ACEI) on Progression of Silent Brain Infarction and Cognitive Decline in Japanese Patients With Essential Hypertension in the Elderly

NCT00126516 is registered in ClinicalTrials.gov with Nara Medical University as lead sponsor.

NCT NCT00126516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Angiotensin II Receptor Blockers (ARB) and Angiotensin Converting Enzyme Inhibitors (ACEI) on Progression of Silent Brain Infarction and Cognitive Decline in Japanese Patients With Essential Hypertension in the Elderly
Lead sponsor
Nara Medical University
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2004
Completion date
June 30, 2013
Enrollment
395 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain infarction, hypertension